SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 114.25 |
Enterprise Value ($M) | 112.16 |
Book Value ($M) | 46.35 |
Book Value / Share | 1.22 |
Price / Book | 2.47 |
NCAV ($M) | 44.57 |
NCAV / Share | 1.17 |
Price / NCAV | 2.56 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.41 |
Return on Assets (ROA) | -0.64 |
Return on Equity (ROE) | -0.71 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 18.14 |
Current Ratio | 18.14 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 47.48 |
Assets | 49.26 |
Liabilities | 2.91 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -21.27 |
Net Income | -19.38 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.73 |
Cash from Investing | -18.30 |
Cash from Financing | 36.84 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | TomEnterprise AB | 11.40 | 51.49 | |
13G/A | Trill Ab | 10.60 | 57.65 | |
13G/A | Jacinto Richard Ii | 12.00 | 82.35 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
881 | 9,703 | 9.08 | |
2,058 | 12,225 | 16.83 | |
1,220 | 24,204 | 5.04 | |
1,366 | 18,196 | 7.51 | |
(click for more detail) |
Similar Companies | |
---|---|
CYTH – Cyclo Therapeutics, Inc. | DARE – DarĂ© Bioscience, Inc. |
DERM – Journey Medical Corporation | DNTH – Dianthus Therapeutics, Inc. |
DRMA – Dermata Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io